Learning Objectives:
1. Review the state-of-the-art of Phase 3 clinical trials in Parkinson´s disease targeting management of motor and non-motor symptoms as well as motor fluctuations
2. Review the progress of clinical trials for disease-modifying therapies targeting cohorts in atypical parkinsonisms
3. Describe advances in clinical trials for essential tremor